UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

FDA Approval Summary: Ruxolitinib for Treatment of Steroid‐Refractory Acute Graft‐Versus‐Host Disease

The oncologist (Dayton, Ohio), 2020-02, Vol.25 (2), p.e328-e334

2020

Volltextzugriff (PDF)

Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses

Journal of clinical oncology, 2022-03, Vol.40 (8), p.847-854

2022

Volltextzugriff (PDF)

Considerations in the development of circulating tumor cell technology for clinical use

Journal of translational medicine, 2012-07, Vol.10 (1), p.138-138, Article 138

2012

Volltextzugriff (PDF)

Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysis

Leukemia, 2020-11, Vol.34 (11), p.3082-3084

2020

Volltextzugriff (PDF)

EBNA1 Regulates Cellular Gene Expression by Binding Cellular Promoters

Proceedings of the National Academy of Sciences - PNAS, 2009-12, Vol.106 (52), p.22421-22426

2009

Volltextzugriff (PDF)

Damage associated molecular pattern molecules

Clinical immunology (Orlando, Fla.), 2007-07, Vol.124 (1), p.1-4

2007

Volltextzugriff (PDF)

Randomized Trial of an Allogeneic Melanoma Lysate Vaccine With Low-Dose Interferon Alfa-2b Compared With High-Dose Interferon Alfa-2b for Resected Stage III Cutaneous Melanoma

Journal of clinical oncology, 2007-05, Vol.25 (15), p.2078-2085

2007

Volltextzugriff (PDF)

An Adenoviral Vector Cancer Vaccine That Delivers a Tumor-Associated Antigen/CD40-Ligand Fusion Protein to Dendritic Cells

Proceedings of the National Academy of Sciences - PNAS, 2003-12, Vol.100 (25), p.15101-15106

2003

Volltextzugriff (PDF)

Normal and Pathological Functions of Mammalian Retroelements

Proceedings of the National Academy of Sciences - PNAS, 2005-08, Vol.102 (35), p.12292-12293

Deisseroth, Albert

2005

Volltextzugriff (PDF)

Vaccination of Rabbits with an Adenovirus Vector Expressing the Papillomavirus E2 Protein Leads to Clearance of Papillomas and Infection

Journal of Virology, 2004-01, Vol.78 (1), p.116-123

2004

Volltextzugriff (PDF)

p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation

Cancer research (Chicago, Ill.), 1995-02, Vol.55 (3), p.668-674

1995

Volltextzugriff (PDF)

STAT3-Mediated Signaling in the Determination of Rod Photoreceptor Cell Fate in Mouse Retina

Investigative ophthalmology & visual science, 2004-07, Vol.45 (7), p.2407-2412

2004

Volltextzugriff (PDF)

Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression

Molecular and Cellular Biology, 1995-06, Vol.15 (6), p.3032-3040

1995

Volltextzugriff (PDF)

Methods for delivery of adenoviral vectors to tumor vasculature

Human gene therapy, 2007-02, Vol.18 (2), p.151-160

2007

Volltextzugriff (PDF)

Genetic Systems for the Diagnosis and Treatment of Human Disease

Cancer biology & therapy, 2004-01, Vol.3 (1), p.126-131

Deisseroth, Albert

2004

Volltextzugriff (PDF)

Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon

Cancer gene therapy, 2003-05, Vol.10 (5), p.388-395

2003

Volltextzugriff (PDF)

Endothelin-3 growth factor levels decreased in cervical cancer compared with normal cervical epithelial cells

Human pathology, 2007-07, Vol.38 (7), p.1047-1056

2007

Volltextzugriff (PDF)

Antitumor immune response induced by i.t. injection of vector-activated dendritic cells and chemotherapy suppresses metastatic breast cancer

Molecular cancer therapeutics, 2006-08, Vol.5 (8), p.1975-1985

2006

Volltextzugriff (PDF)

Acute Myeloid Leukemia Response Measures Other Than Complete Remission

Journal of clinical oncology, 2015-11, Vol.33 (31), p.3675-3676

2015

Volltextzugriff (PDF)

Abstract 5911: A bicistronic adenoviral vector carrying cytosine deaminase and GM-CSF genes significantly improves antitumor immunity and overall survival in colon cancer

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5911-5911

2018

Volltextzugriff (PDF)

Quantitative Relationship Between AUEC of Absolute Neutrophil Count and Duration of Severe Neutropenia for G‐CSF in Breast Cancer Patients

Clinical pharmacology and therapeutics, 2018-10, Vol.104 (4), p.742-748

2018

Volltextzugriff (PDF)

Interaction of nuclear proteins with an AP-1/CRE-like promoter sequence in the human TNF-alpha gene

Journal of leukocyte biology, 1994-07, Vol.56 (1), p.27-35

1994

Volltextzugriff (PDF)

Incidence of Differentiation Syndrome with Ivosidenib (IVO) and Enasidenib (ENA) for Treatment of Patients with Relapsed or Refractory (R/R) Isocitrate Dehydrogenase (IDH)1- or IDH2-Mutated Acute Myeloid Leukemia (AML): A Systematic Analysis By the U.S. Food and Drug Administration (FDA)

Blood, 2018-11, Vol.132 (Supplement 1), p.288-288

2018

Volltextzugriff (PDF)

International Society for Cell and Gene Therapy of Cancer (ISCGT) annual meeting: conference overview and introduction to the symposium papers

Cancer Immunology, Immunotherapy, 2006-11, Vol.55 (11), p.1406-1411

2006

Volltextzugriff (PDF)

Recombinant adenoviral vector containing tumor-specific L-plastin promoter fused to cytosine deaminase gene as a transcription unit: generation and functional test

Archives of pharmacal research, 2004-06, Vol.27 (6), p.633-639

2004

Volltextzugriff (PDF)

1 – 25 von 245

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieClinical Cancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(233)
Mit Volltextzugriff
(214)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(178)
Humans
(171)
Life Sciences & Biomedicine
(169)
Biological And Medical Sciences
(80)
Female
(63)
Medical Sciences
(62)
Oncology
(61)
Hematology
(59)
Animals
(53)
Adult
(46)
Male
(45)
Middle Aged
(41)
Base Sequence
(33)
Molecular Sequence Data
(29)
Mice
(28)
Bone Marrow Transplantation
(24)
Hematologic And Hematopoietic Diseases
(23)
Tumor Cells, Cultured
(23)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(22)
Fundamental And Applied Biological Sciences. Psychology
(21)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

FDA Approval Summary: Ruxolitinib for Treatment of Steroid‐Refractory Acute Graft‐Versus‐Host Disease

Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses

Considerations in the development of circulating tumor cell technology for clinical use

Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysis

EBNA1 Regulates Cellular Gene Expression by Binding Cellular Promoters

Damage associated molecular pattern molecules

Randomized Trial of an Allogeneic Melanoma Lysate Vaccine With Low-Dose Interferon Alfa-2b Compared With High-Dose Interferon Alfa-2b for Resected Stage III Cutaneous Melanoma

An Adenoviral Vector Cancer Vaccine That Delivers a Tumor-Associated Antigen/CD40-Ligand Fusion Protein to Dendritic Cells

Normal and Pathological Functions of Mammalian Retroelements

Vaccination of Rabbits with an Adenovirus Vector Expressing the Papillomavirus E2 Protein Leads to Clearance of Papillomas and Infection

p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation

STAT3-Mediated Signaling in the Determination of Rod Photoreceptor Cell Fate in Mouse Retina

Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression

Methods for delivery of adenoviral vectors to tumor vasculature

Genetic Systems for the Diagnosis and Treatment of Human Disease

Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon

Endothelin-3 growth factor levels decreased in cervical cancer compared with normal cervical epithelial cells

Antitumor immune response induced by i.t. injection of vector-activated dendritic cells and chemotherapy suppresses metastatic breast cancer

Acute Myeloid Leukemia Response Measures Other Than Complete Remission

Abstract 5911: A bicistronic adenoviral vector carrying cytosine deaminase and GM-CSF genes significantly improves antitumor immunity and overall survival in colon cancer

Quantitative Relationship Between AUEC of Absolute Neutrophil Count and Duration of Severe Neutropenia for G‐CSF in Breast Cancer Patients

Interaction of nuclear proteins with an AP-1/CRE-like promoter sequence in the human TNF-alpha gene

Incidence of Differentiation Syndrome with Ivosidenib (IVO) and Enasidenib (ENA) for Treatment of Patients with Relapsed or Refractory (R/R) Isocitrate Dehydrogenase (IDH)1- or IDH2-Mutated Acute Myeloid Leukemia (AML): A Systematic Analysis By the U.S. Food and Drug Administration (FDA)

International Society for Cell and Gene Therapy of Cancer (ISCGT) annual meeting: conference overview and introduction to the symposium papers

Recombinant adenoviral vector containing tumor-specific L-plastin promoter fused to cytosine deaminase gene as a transcription unit: generation and functional test

Aktive Filter

Suchergebnisse filtern